Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
c-Rel gain in B cells drives germinal center reactions and autoantibody production
Maike Kober-Hasslacher, Hyunju Oh-Strauß, Dilip Kumar, Valeria Soberon, Carina Diehl, Maciej Lech, Thomas Engleitner, Eslam Katab, Vanesa Fernández-Sáiz, Guido Piontek, Hongwei Li, Björn Menze, Christoph Ziegenhain, Wolfgang Enard, Roland Rad, Jan P. Böttcher, Hans-Joachim Anders, Martina Rudelius, Marc Schmidt-Supprian
Maike Kober-Hasslacher, Hyunju Oh-Strauß, Dilip Kumar, Valeria Soberon, Carina Diehl, Maciej Lech, Thomas Engleitner, Eslam Katab, Vanesa Fernández-Sáiz, Guido Piontek, Hongwei Li, Björn Menze, Christoph Ziegenhain, Wolfgang Enard, Roland Rad, Jan P. Böttcher, Hans-Joachim Anders, Martina Rudelius, Marc Schmidt-Supprian
View: Text | PDF
Research Article Autoimmunity Immunology

c-Rel gain in B cells drives germinal center reactions and autoantibody production

  • Text
  • PDF
Abstract

Single-nucleotide polymorphisms and locus amplification link the NF-κB transcription factor c-Rel to human autoimmune diseases and B cell lymphomas, respectively. However, the functional consequences of enhanced c-Rel levels remain enigmatic. Here, we overexpressed c-Rel specifically in mouse B cells from BAC-transgenic gene loci and demonstrate that c-Rel protein levels linearly dictated expansion of germinal center B (GCB) cells and isotype-switched plasma cells. c-Rel expression in B cells of otherwise c-Rel–deficient mice fully rescued terminal B cell differentiation, underscoring its critical B cell–intrinsic roles. Unexpectedly, in GCB cells transcription-independent regulation produced the highest c-Rel protein levels among B cell subsets. In c-Rel–overexpressing GCB cells this caused enhanced nuclear translocation, a profoundly altered transcriptional program, and increased proliferation. Finally, we provide a link between c-Rel gain and autoimmunity by showing that c-Rel overexpression in B cells caused autoantibody production and renal immune complex deposition.

Authors

Maike Kober-Hasslacher, Hyunju Oh-Strauß, Dilip Kumar, Valeria Soberon, Carina Diehl, Maciej Lech, Thomas Engleitner, Eslam Katab, Vanesa Fernández-Sáiz, Guido Piontek, Hongwei Li, Björn Menze, Christoph Ziegenhain, Wolfgang Enard, Roland Rad, Jan P. Böttcher, Hans-Joachim Anders, Martina Rudelius, Marc Schmidt-Supprian

×

Figure 6

c-Rel protein nuclear translocation during terminal B cell differentiation.

Options: View larger image (or click on image) Download as PowerPoint
c-Rel protein nuclear translocation during terminal B cell differentiati...
(A–D) Imaging flow cytometry analyses to assess c-Rel nuclear translocation in B cells (B220+CD38+CD95–) and GCB cells (B220+CD95hiCD38lo) in LNs. Cells were stimulated with anti-CD40 for 60 minutes or left unstimulated in the presence of the pan-caspase inhibitor Q-VD-OPh to prolong survival of GCB cells. (A) Representative images of c-Rel nuclear translocation in unstimulated cells. Images were selected based on average nuclear localization score. Scale bars: 10 μm. (B) Quantified c-Rel nuclear translocation score in unstimulated or anti-CD40–stimulated B cells and GCB cells. Individual data points were pooled from 4 mice per genotype obtained in 3 independent experiments (pooled data points for CD19CreI/+: B unstimulated, n = 67,148; B stimulated, n = 75,884; GCB unstimulated, n = 1129; GCB stimulated, n = 1267; pooled data points for RelTG CD19CreI/+: B unstimulated, n = 80,494; B stimulated, n = 89,012; GCB unstimulated, n = 1861; GCB stimulated, n = 1951). Bars and numbers below graphs represent mean values calculated from the mean nuclear translocation scores for each mouse. (C) Histograms to visualize the frequency distribution of nuclear translocation scores for a representative mouse for each genotype. (D) Percentage of cells within the population of unstimulated B and GCB cells with a nuclear translocation score of 2.7 or more. Individual data points for 4 mice per genotype obtained in 3 independent experiments and bars representing mean values are shown. (E) c-Rel protein analyzed by capillary Western blot. Non-GCB (B) and GCB cells were FACS-sorted 7–9 days after SRBC immunization followed by nuclear fractionation. Each data point represents 1 sample of 1 × 106 cells sorted from 2–3 mice. For quantification, c-Rel protein signals were normalized to PTEN (cytosol) or lamin B2 (nucleus). BF, bright field; Nuc, nucleus; Cyt, cytosol. See Supplemental Figure 7.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts